1. A currently enrolling randomized controlled trial is comparing approaches to pharmacomechanical thrombectomy for deep vein thrombosis (DVT). 
2. Investigators hope their findings will improve vein patency and reduce risks of post-thrombotic syndrome. 
3. 160 patients aged 18 to 80 years with newly diagnosed whole-limb DVT are enrolled in the study.
4. Researchers are evaluating primary and secondary outcomes over 24 months. 
5. The findings are anticipated to clarify the role of modified venous access in improving thrombectomy for extensive DVT and inform future treatment strategies.

Source: BMJ Open